These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3018345)

  • 1. In vivo immunologic selection of proviral gene deletion variants from a nonproducer clone.
    Tanio Y; Talmadge C; Dekaban G; Hovis J; Ohanian SH; Zbar B
    J Natl Cancer Inst; 1986 Sep; 77(3):767-75. PubMed ID: 3018345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-clonal interactions in the generation of proviral gene deletion variants.
    Zbar B; Tanio Y
    J Natl Cancer Inst; 1987 Aug; 79(2):383-8. PubMed ID: 3474468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.
    Zbar B; Terata N; Nagai A; Tanio Y; Hovis J
    Cancer Res; 1984 Oct; 44(10):4622-9. PubMed ID: 6088041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma.
    Zbar B; Sukumar S; Tanio Y; Terata N; Hovis J
    Cancer Res; 1984 Nov; 44(11):5079-85. PubMed ID: 6488168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subversion of the innate immune system by a retrovirus.
    Jude BA; Pobezinskaya Y; Bishop J; Parke S; Medzhitov RM; Chervonsky AV; Golovkina TV
    Nat Immunol; 2003 Jun; 4(6):573-8. PubMed ID: 12730691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
    Iglehart JD; Ward EC; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provirus integration of bovine leukemia virus into DNA of infected human myeloma cells.
    Sláviková K; Kettmann R; Reinerová M; Zajac V; Portetelle D; Burny A
    Neoplasma; 1987; 34(6):653-7. PubMed ID: 2829042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells.
    Nagai A; Zbar B; Terata N; Hovis J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
    Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant retrovirus carrying a non-producer human immunodeficiency virus (HIV) type 1 variant induces resistance to superinfecting HIV.
    Federico M; Taddeo B; Carlini F; Nappi F; Verani P; Rossi GB
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2099-110. PubMed ID: 8409934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo immunologic selection of class I major histocompatibility complex gene deletion variants from the B16-BL6 melanoma.
    Talmadge JE; Talmadge CB; Zbar B; McEwen R; Meeker AK; Tribble H
    J Natl Cancer Inst; 1987 Jun; 78(6):1215-21. PubMed ID: 3473258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradual elimination of retroviruses in YBR/Ei mice.
    MacDearmid CC; Case LK; Starling CL; Golovkina TV
    J Virol; 2006 Mar; 80(5):2206-15. PubMed ID: 16474128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B; Nagai A; Terata N; Hovis J
    Cancer Res; 1983 Jan; 43(1):46-53. PubMed ID: 6182993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Superantigens and murine mammary tumor retrovirus].
    Piazzon I; Nepomnaschy I; Buggiano V; Bekinschtein P; Goldman A; Berguer P; Deroche A; Lombardi G
    Medicina (B Aires); 1997; 57 Suppl 2():21-33. PubMed ID: 9567341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.
    Purdy A; Case L; Duvall M; Overstrom-Coleman M; Monnier N; Chervonsky A; Golovkina T
    J Exp Med; 2003 Jan; 197(2):233-43. PubMed ID: 12538662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The location in cartilage of infectious retrovirus in cats infected with feline leukemia virus.
    Arnoczky SP; Swenson C; Egerbacher M; Gardner K; Caballero O; Burns M
    J Bone Joint Surg Am; 2007 Sep; 89(9):2030-6. PubMed ID: 17768202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.